Quarterly report [Sections 13 or 15(d)]

Accounts Payable and Accrued Expenses

Accounts Payable and Accrued Expenses	3 Months Ended
Mar. 31, 2026
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses	Note 4. Accounts Payable and Accrued Expenses Accounts payable and accrued expenses totaled $1.3 million as of March 31, 2026, compared to $1.6 million as of December 31, 2025. The decrease was primarily attributable to the timing of vendor invoicing and payments and higher accrued research and development expenses related to ongoing ONP-002 program activities during the quarter. These liabilities consist primarily of account payables to research and development vendors, payroll and benefits accruals, professional service fees, and other general corporate obligations.

Accounts Payable and Accrued Expenses

3 Months Ended

Mar. 31, 2026

Note 4. Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses totaled $1.3 million as of March 31, 2026, compared to $1.6 million as of December 31, 2025. The decrease was primarily attributable to the timing of vendor invoicing and payments and higher accrued research and development expenses related to ongoing ONP-002 program activities during the quarter.

These liabilities consist primarily of account payables to research and development vendors, payroll and benefits accruals, professional service fees, and other general corporate obligations.